评估药物 - 药物相互作用与药代动力学增强剂的风险 : 利托那韦增强尼马特雷韦预防严重 COVID - 19 的案例。
关键词: Antivirals COVID-19 Drug safety Drug-drug interactions Nirmatrelvir Pharmacokinetic boosters Ritonavir Antivirals COVID-19 Drug safety Drug-drug interactions Nirmatrelvir Pharmacokinetic boosters Ritonavir Antivirals COVID-19 Drug safety Drug-drug interactions Nirmatrelvir Pharmacokinetic boosters Ritonavir
Mesh : Antiviral Agents / therapeutic use COVID-19 / drug therapy Drug Interactions Humans Ritonavir / pharmacokinetics therapeutic use SARS-CoV-2 Antiviral Agents / therapeutic use COVID-19 / drug therapy Drug Interactions Humans Ritonavir / pharmacokinetics therapeutic use SARS-CoV-2
来 源:
DOI:10.1016/j.cmi.2022.03.030
PDF(Pubmed)